-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, U1W/rpi0kB4lQPp95Yh6MSOy+KDdG3jsxurK8Ergj8o/Lv8x/lWqAQ3x+YW0tUkO LLGtsSimPEyzWpsW5VdpiQ== 0000310158-03-000070.txt : 20030826 0000310158-03-000070.hdr.sgml : 20030826 20030826150814 ACCESSION NUMBER: 0000310158-03-000070 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 2 CONFORMED PERIOD OF REPORT: 20030826 ITEM INFORMATION: Other events ITEM INFORMATION: Financial statements and exhibits FILED AS OF DATE: 20030826 FILER: COMPANY DATA: COMPANY CONFORMED NAME: SCHERING PLOUGH CORP CENTRAL INDEX KEY: 0000310158 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 221918501 STATE OF INCORPORATION: NJ FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-06571 FILM NUMBER: 03866430 BUSINESS ADDRESS: STREET 1: ONE GIRALDA FARMS CITY: MADISON STATE: NJ ZIP: 07940-1000 BUSINESS PHONE: 9738227000 8-K 1 eightk.htm SECURITIES AND EXCHANGE COMMISSION

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 8-K

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

August 26, 2003

Date of Report (Date of Earliest Event Reported)

Schering-Plough Corporation

(Exact name of registrant as specified in its charter)

     

New Jersey

1-6571

22-1918501

(State or other jurisdiction
of incorporation)

(Commission File Number)

(IRS Employer
Identification Number)

 

 

2000 Galloping Hill Road
Kenilworth, NJ 07033

(Address of principal executive offices, including Zip Code)

(908) 298-4000

(Registrant's telephone number, including area code)

   

 

Item 5. Other Events and Regulation FD Disclosure

Moody's Investors Services issued a press release August 26, 2003 titled "Moody's Places Ratings Of Schering-Plough Corporation (P)A1 Long Term; Prime-1 Short Term) Under Review For Possible Downgrade." The press release is attached to this 8-K as Exhibit 99.1.

Item 7. Financial Statements and Exhibits

(c) Exhibits. The following exhibit is filed with this 8-K:

99.1 Press Release issued by Moody's Investors Services August 26, 2003 titled "Moody's Places Ratings Of Schering-Plough Corporation (P)A1 Long Term; Prime-1 Short Term) Under Review for Possible Downgrade"

SIGNATURES

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Schering-Plough Corporation

 

 

 

By: /s/Thomas H. Kelly

Thomas H. Kelly

Vice President and Controller

Date: August 26, 2003

Exhibit Index

The following exhibit is filed with this 8-K:

99.1 Press Release issued by Moody's Investors Service August 26, 2003 titled "Moody's Places Ratings Of Schering-Plough Corporation (P)A1 Long Term; Prime-1 Short Term) Under Review for Possible Downgrade"

EX-99.1 3 pressrel.htm Global Credit Research

Exhibit 99.1

Global Credit Research

Rating Action

26 AUG 2003

Rating Action: Schering-Plough Corporation

 

 

MOODY'S PLACES RATINGS OF SCHERING-PLOUGH CORPORATION ((P)A1 LONG TERM; PRIME-1 SHORT TERM) UNDER REVIEW FOR POSSIBLE DOWNGRADE

 

 

Approximately $1.9 Billion of Rated Securities Affected.

New York, August 26, 2003 - Moody's Investors Service placed the ratings of Schering-Plough Corporation under review for possible downgrade.

 

Ratings placed under review for possible downgrade:

 

Schering-Plough Corporation: (P)A1 shelf registration, Prime-1 commercial paper

Schering Corporation: Prime-1 commercial paper

 

The rating review is prompted by Moody's concerns that Schering-Plough's operating cash flow may fall significantly below the rating agency's earlier expectations as a result of declining sales and market share of key products combined with higher investment to support Zetia and the Zetia/Zocor combination. In addition, Moody's is concerned that Schering-Plough's free cash flow, even with the announced reduction in shareholder dividend, may also fall below Moody's earlier expectations and/or remain negative over a longer time frame.

 

Moody's rating review will focus on (1) performance of key product franchises in the wake of increasing branded competition and potential generic competition; (2) additional steps management is taking to stabilize performance, including headcount reduction; (3) the potential for additional cash outflows associated with ongoing litigation; and (4) the impact of lower operating cash flow and potentially lower free cash flow on Schering-Plough's balance sheet, which Moody's believes remains healthy, currently.

 

At this time, Moody's expects that the rating change, if any, could be one or two notches; hence, Moody's is placing both the (P)A1 long-term as well as the Prime-1 short term debt ratings under review for possible downgrade. Moody's notes that Schering-Plough's liquidity remains very good, based on cash and short term investments of $4.1 billion reported as of June 30, 2003 compared to total debt and preferred equity securities of $2.1 billion, with limited near term maturities. In addition, the company maintains $1 billion of committed bank facilities without restrictive covenants or onerous conditions precedent to borrowing. This liquidity should provide flexibility to withstand weaker operating cash flow, potentially negative free cash flow, and potential outflows associated with litigation.

 

Headquartered in Kenilworth, New Jersey, Schering-Plough Corporation is a worldwide pharmaceutical company with activities in human and animal health and consumer products. Sales in 2002 totaled $10.2 billion.

 

New York

Patrick Finnegan

Managing Director

Corporate Finance Group

Moody's Investors Service

JOURNALISTS: 212-553-0376

SUBSCRIBERS: 212-553-1653

 

New York

Michael Levesque

Senior Analyst

Corporate Finance Group

Moody's Investors Service

JOURNALISTS: 212-553-0376

SUBSCRIBERS: 212-553-1653

 

 

 

 

 

Copyright 2003, Moody's Investors Service, Inc. and/or its licensors including Moody's Assurance Company, Inc. (together, MOODY'S). All rights reserved.

-----END PRIVACY-ENHANCED MESSAGE-----